Gordon A. Jones

Array ( [id] => 18148918 [patent_doc_number] => 20230022775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => RIBOREGULATORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/784899 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17126581 [patent_doc_number] => 20210301350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => LUNG CANCER DETERMINATIONS USING MIRNA [patent_app_type] => utility [patent_app_number] => 17/097408 [patent_app_country] => US [patent_app_date] => 2020-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20554 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17126581 [patent_doc_number] => 20210301350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => LUNG CANCER DETERMINATIONS USING MIRNA [patent_app_type] => utility [patent_app_number] => 17/097408 [patent_app_country] => US [patent_app_date] => 2020-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20554 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18597675 [patent_doc_number] => 20230272472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => DIFFERENTIAL DIAGNOSIS OF BIPOLAR DISORDER AND UNIPOLAR DEPRESSION BY BLOOD RNA EDITING BIOMARKERS [patent_app_type] => utility [patent_app_number] => 17/774752 [patent_app_country] => US [patent_app_date] => 2020-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18597675 [patent_doc_number] => 20230272472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => DIFFERENTIAL DIAGNOSIS OF BIPOLAR DISORDER AND UNIPOLAR DEPRESSION BY BLOOD RNA EDITING BIOMARKERS [patent_app_type] => utility [patent_app_number] => 17/774752 [patent_app_country] => US [patent_app_date] => 2020-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17946182 [patent_doc_number] => 20220333199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => Diagnostic Chromosome Marker [patent_app_type] => utility [patent_app_number] => 17/641666 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15250 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18583261 [patent_doc_number] => 20230265521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => BODY FLUID EXTRACT CONTAINING MICRO RNA [patent_app_type] => utility [patent_app_number] => 17/641054 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 121921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -89 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17960395 [patent_doc_number] => 20220340975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => METHOD OF TREATMENT AND PRONOSTIC OF ACUTE MYELOID LEUKEMIA [patent_app_type] => utility [patent_app_number] => 17/637235 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17946191 [patent_doc_number] => 20220333208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => CRISPR EFFECTOR SYSTEM BASED MULTIPLEX CANCER DIAGNOSTICS [patent_app_type] => utility [patent_app_number] => 17/640016 [patent_app_country] => US [patent_app_date] => 2020-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17735011 [patent_doc_number] => 20220220470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => PROBE-CAPTURE METHOD FOR TCR ALPHA AND BETA CHAIN VDJ-RECOVERY FROM OLIGO-DT REVERSE TRANSCRIBED RNA [patent_app_type] => utility [patent_app_number] => 17/635219 [patent_app_country] => US [patent_app_date] => 2020-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17830553 [patent_doc_number] => 20220267857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => METHOD FOR DETERMINING THE RESPONSE TO TREATMENT OF A PATIENT AFFECTED BY NON-SMALL CELL LUNG CARCINOMA (NSCLC) [patent_app_type] => utility [patent_app_number] => 17/628179 [patent_app_country] => US [patent_app_date] => 2020-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17830553 [patent_doc_number] => 20220267857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => METHOD FOR DETERMINING THE RESPONSE TO TREATMENT OF A PATIENT AFFECTED BY NON-SMALL CELL LUNG CARCINOMA (NSCLC) [patent_app_type] => utility [patent_app_number] => 17/628179 [patent_app_country] => US [patent_app_date] => 2020-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17830553 [patent_doc_number] => 20220267857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => METHOD FOR DETERMINING THE RESPONSE TO TREATMENT OF A PATIENT AFFECTED BY NON-SMALL CELL LUNG CARCINOMA (NSCLC) [patent_app_type] => utility [patent_app_number] => 17/628179 [patent_app_country] => US [patent_app_date] => 2020-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17750002 [patent_doc_number] => 20220228207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => POLYMORPHIC MARKERS FOR PHARMACOGENETIC HLA RISK ALLELES [patent_app_type] => utility [patent_app_number] => 17/616615 [patent_app_country] => US [patent_app_date] => 2020-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17705012 [patent_doc_number] => 20220205018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => MICROFLUIDIC CHIP ASSEMBLY FOR RAPIDLY PERFORMING DIGITAL POLYMERASE CHAIN REACTION (PCR), AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/620725 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17705012 [patent_doc_number] => 20220205018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => MICROFLUIDIC CHIP ASSEMBLY FOR RAPIDLY PERFORMING DIGITAL POLYMERASE CHAIN REACTION (PCR), AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/620725 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17642373 [patent_doc_number] => 20220170111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => SALIVARY BIOMARKERS FOR THE DETECTION OF EPIDERMOID CANCER OF THE HEAD AND NECK [patent_app_type] => utility [patent_app_number] => 17/601382 [patent_app_country] => US [patent_app_date] => 2020-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17642373 [patent_doc_number] => 20220170111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => SALIVARY BIOMARKERS FOR THE DETECTION OF EPIDERMOID CANCER OF THE HEAD AND NECK [patent_app_type] => utility [patent_app_number] => 17/601382 [patent_app_country] => US [patent_app_date] => 2020-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17705051 [patent_doc_number] => 20220205057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => COMPOSITION OF PRIMERS FOR DETECTING HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION [patent_app_type] => utility [patent_app_number] => 17/593447 [patent_app_country] => US [patent_app_date] => 2020-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47627 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17593447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17595788 [patent_doc_number] => 20220145362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => METHODS AND SYSTEMS FOR PROCESSING OR ANALYZING OLIGONUCLEOTIDE ENCODED MOLECULES [patent_app_type] => utility [patent_app_number] => 17/438900 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438900 [rel_patent_id] =>[rel_patent_doc_number] =>)